
Keywords: سرطان ریه سلول غیر سلولی; RNA metabolism; prognosis; adjuvant chemotherapy; lung cancer; adenocarcinoma; squamous cell carcinoma; CI; confidence interval; DCC; Director's Challenge Consortium (for the Molecular Classification of Lung Adenocarcinoma); NSCLC; non-small cell lung c